147 related articles for article (PubMed ID: 37318681)
1. Predicting the effect of different folate doses on [
Siebinga H; Hendrikx JJMA; Huitema ADR; de Wit-van der Veen BJ
EJNMMI Res; 2023 Jun; 13(1):60. PubMed ID: 37318681
[TBL] [Abstract][Full Text] [Related]
2. What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake.
Kuo HT; Lin KS; Zhang Z; Zhang C; Merkens H; Tan R; Roxin A; Uribe CF; Bénard F
Theranostics; 2022; 12(14):6179-6188. PubMed ID: 36168623
[TBL] [Abstract][Full Text] [Related]
3. A physiologically based pharmacokinetic model for [
Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Dorlo TPC; Huitema ADR; Hendrikx JJMA
EJNMMI Res; 2023 Feb; 13(1):8. PubMed ID: 36735114
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
7. A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [
Huang SS; DiFilippo FP; Lindner DJ; Heston WD
EJNMMI Radiopharm Chem; 2024 Jan; 9(1):7. PubMed ID: 38289450
[TBL] [Abstract][Full Text] [Related]
8. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
10. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
[TBL] [Abstract][Full Text] [Related]
11. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [
Nail V; Louis B; Moyon A; Chabert A; Balasse L; Fernandez S; Hache G; Garrigue P; Taïeb D; Guillet B
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745848
[TBL] [Abstract][Full Text] [Related]
12. Tumor Sink Effect in
Gafita A; Wang H; Robertson A; Armstrong WR; Zaum R; Weber M; Yagubbayli F; Kratochwil C; Grogan TR; Nguyen K; Navarro F; Esfandiari R; Rauscher I; Menze B; Elashoff D; Delpassand ES; Herrmann K; Czernin J; Hofman MS; Calais J; Fendler WP; Eiber M
J Nucl Med; 2022 Feb; 63(2):226-232. PubMed ID: 34049987
[TBL] [Abstract][Full Text] [Related]
13. Predicting [
Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Stokkel MPM; Dorlo TPC; Huitema ADR; Hendrikx JJMA
EJNMMI Phys; 2023 Aug; 10(1):48. PubMed ID: 37615812
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual comparison of
Ferreira G; Iravani A; Hofman MS; Hicks RJ
Cancer Imaging; 2019 May; 19(1):23. PubMed ID: 31092293
[TBL] [Abstract][Full Text] [Related]
15.
Junqueira MZ; Rocha NH; Sapienza MT
Radiol Bras; 2021; 54(3):171-176. PubMed ID: 34108764
[TBL] [Abstract][Full Text] [Related]
16. First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for
Rupp NJ; Umbricht CA; Pizzuto DA; Lenggenhager D; Töpfer A; Müller J; Muehlematter UJ; Ferraro DA; Messerli M; Morand GB; Huber GF; Eberli D; Schibli R; Müller C; Burger IA
J Nucl Med; 2019 Sep; 60(9):1270-1276. PubMed ID: 30737300
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Monosodium Glutamate on
Armstrong WR; Gafita A; Zhu S; Thin P; Nguyen K; Alano R; Lira S; Booker K; Gardner L; Grogan T; Elashoff D; Allen-Auerbach M; Dahlbom M; Czernin J; Calais J
J Nucl Med; 2021 Sep; 62(9):1244-1251. PubMed ID: 33509974
[TBL] [Abstract][Full Text] [Related]
18. [
Peters SMB; Hofferber R; Privé BM; de Bakker M; Gotthardt M; Janssen M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Costa PF; Nagarajah J; Konijnenberg MW; Jentzen W
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1101-1112. PubMed ID: 34623453
[TBL] [Abstract][Full Text] [Related]
19. The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function.
Li JF; Qin LP; Wu QY; Guo XH; Yang JZ; Wan QC; Cheng MH; Xie LJ
Clin Rheumatol; 2022 May; 41(5):1543-1550. PubMed ID: 35089469
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.
Mohan V; Bruin NM; Tesselaar MET; de Boer JP; Vegt E; Hendrikx JJMA; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
EJNMMI Res; 2021 Mar; 11(1):25. PubMed ID: 33710423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
